 "Jubilant Life Sciences falls 11% after block deals")
Jubilant Life Sciences has slipped 11% to Rs 883 on the National Stock Exchange (NSE) in intra-day trade on Friday after more than 7% of the total equity of pharmaceutical company changed hands on the NSE and BSE till noon deal. The exchanges data showing that a multiple block deals executed on the counter in early trade.
Till 11:47 am; a combined 12.07 million equity shares representing 7.59% of total equity of Jubilant Life Sciences changed hands on the NSE and BSE. The stock was trading 9% lower at Rs 903 on the BSE, as compared to 0.72% rise in the S&P BSE Sensex.
Till 11:47 am; a combined 12.07 million equity shares representing 7.59% of total equity of Jubilant Life Sciences changed hands on the NSE and BSE. The stock was trading 9% lower at Rs 903 on the BSE, as compared to 0.72% rise in the S&P BSE Sensex.
The names of the buyers and sellers not ascertained immediately.
As of December 31, 2017, the promoters were holding 54.02% stake in the company.
Jubilant Life Sciences had a strong run-up by gaining 26% thus far in the current calendar year 2018, against 0.7% decline in the benchmark Sensex till Thursday.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%